Evidence map›Paper›PMID 33488942›Full record

ArticleOxidative medicine and cellular longevity2021

The Effects of Dandelion Polysaccharides on Iron Metabolism by Regulating Hepcidin

Feng Ren, Yingying Yang, Kaixuan Wu, Tiesuo Zhao, Yinghao Shi, Moxuan Song, Jian Li

Open access · hybridAbstract read
In one paragraph

Article in Oxidative medicine and cellular longevity, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 24 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
24citing papers in PubMed, 1 pooled it
4.2field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

24 citing papers in PubMed, 1 synthesis or guideline pooled it, 36 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Review
  4. Review
  5. Article
  6. Review
  7. Review
  8. Review
  9. Review
  10. Article
  11. Review
  12. Review
  13. Research Progress on the Anticancer Activity of Plant Polysaccharides.Recent patents on anti-cancer drug discovery · 2024
    Review
  14. Review
  15. Article
  16. Review
  17. Iron as a therapeutic target in chronic liver disease.World journal of gastroenterology · 2023
    Review
  18. Review
  19. Hepcidin in hepatocellular carcinoma.British journal of cancer · 2022
    Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

Feng RenSchool of Basic Medical Sciences, Xinxiang Medical University, Xinxiang 453003, China.ORCID https://orcid.org/0000-0001-9913-7979
Yingying YangSchool of Nursing, Xinxiang Medical University, Xinxiang 453003, China.
Kaixuan WuSchool of Nursing, Xinxiang Medical University, Xinxiang 453003, China.
Tiesuo ZhaoSchool of Basic Medical Sciences, Xinxiang Medical University, Xinxiang 453003, China.
Yinghao ShiSchool of Basic Medical Sciences, Xinxiang Medical University, Xinxiang 453003, China.
Moxuan SongSchool of Basic Medical Sciences, Xinxiang Medical University, Xinxiang 453003, China.
Jian LiSchool of Forensic Medicine, Xinxiang Medical University, Xinxiang 453003, China.ORCID https://orcid.org/0000-0002-5978-0991
Xinxiang Medical University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Recent studies have claimed that iron overload was correlated with the risk of hepatocellular carcinoma (HCC), and our previous studies have also demonstrated that dandelion polysaccharide (DP) suppressed HCC cell line proliferation via causing cell cycle arrest and inhibiting the PI3K/AKT/mTOR pathway, but the effect of DP on metabolism is still not very clear. Here, we aim to clarify the effects of DP on iron metabolism and the underlying mechanism. In this study, we found that DP could reduce iron burden in hepatoma cells and grafted tumors. Hepcidin is a central regulator in iron metabolism. We confirmed that the expression of hepcidin in HCC tumor tissues was significantly higher than that in the adjacent nontumor tissues. The expression of hepcidin was downregulated in the liver of mouse model treatment with DP, as well as in hepatoma cells. Moreover, RNA sequencing and western blot data revealed that DP inhibited the IL-6-activated JAK-STAT signaling pathway. In summary, our results revealed that DP might be a new potential drug candidate for the regulation of iron burden and the treatment of HCC.

Indexed as

AnimalsApoptosisCarcinoma, HepatocellularCell ProliferationGene Expression Regulation, NeoplasticHumansIronJanus KinasesLiver NeoplasmsMiceMice, Inbred BALB CMice, NudePolysaccharidesSTAT Transcription FactorsTaraxacumTumor Cells, CulturedIronJanus KinasesPolysaccharidesSTAT Transcription Factors

Identifiers

PMID33488942
PMCPMC7801049
OpenAlexW3119611143

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.